{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:12:17Z","timestamp":1792876337361,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C33589\/A28284"],"award-info":[{"award-number":["C33589\/A28284"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7224\/A28724"],"award-info":[{"award-number":["C7224\/A28724"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.prro.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:17:22Z","timestamp":1729059442000},"page":"e172-e188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Stereotactic Body Radiation therapy for Liver Metastases: Systematic Review and Meta-Analysis With International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-6284","authenticated-orcid":false,"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison C.","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.09.011_bib0001","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0002","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2024.09.011_bib0004","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ags3.12276","article-title":"How to increase the resectability of initially unresectable colorectal liver metastases: a surgical perspective","volume":"3","author":"Imai","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"issue":"6","key":"10.1016\/j.prro.2024.09.011_bib0005","article-title":"Radiofrequency ablation in the treatment of liver metastases from colorectal cancer","author":"Cirocchi","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2024.09.011_bib0006","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2024.09.011_bib0007","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0008","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients With oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0009","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00130404-200403000-00009","article-title":"The role of radiotherapy in the treatment of liver metastases","volume":"10","author":"Dawson","year":"2004","journal-title":"Cancer J"},{"key":"10.1016\/j.prro.2024.09.011_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.prro.2024.09.011_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-015-0369-9","article-title":"Stereotactic radiation therapy for liver metastases: factors affecting local control and survival","volume":"10","author":"Andratschke","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","volume":"18","author":"Andratschke","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2024.09.011_bib0014","doi-asserted-by":"crossref","first-page":"330","DOI":"10.21037\/jgo.2018.11.03","article-title":"Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases","volume":"10","author":"Anstadt","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/hpb.12044","article-title":"Multicentre results of stereotactic body radiotherapy for secondary liver tumours","volume":"15","author":"Berber","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.prro.2024.09.011_bib0016","first-page":"349","article-title":"Stereotactic robotic body radiotherapy for patients with unresectable hepatic oligorecurrence","volume":"16","author":"Berkovic","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.prro.2024.09.011_bib0017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-717X-7-92","article-title":"Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases\u2013clinical results","volume":"7","author":"Boda-Heggemann","year":"2012","journal-title":"Radiat Oncol"},{"issue":"suppl 2","key":"10.1016\/j.prro.2024.09.011_bib0018","first-page":"2S93","article-title":"Stereotactic body radiation therapy for colorectal cancer liver metastases; early results","volume":"25","author":"Burkon","year":"2012","journal-title":"Klin Onkol"},{"key":"10.1016\/j.prro.2024.09.011_bib0019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5644\/ama2006-124.311","article-title":"Stereotactic body radiation therapy (SBRT) for liver oligometastases: outcomes and safety","volume":"49","author":"Cazic","year":"2020","journal-title":"Acta Med Acad"},{"key":"10.1016\/j.prro.2024.09.011_bib0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3857\/roj.2017.00024","article-title":"Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors","volume":"35","author":"Cha","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2024.09.011_bib0021","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/cncr.25997","article-title":"Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.09.011_bib0022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00066-019-01524-8","article-title":"Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors","volume":"196","author":"Clerici","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2024.09.011_bib0023","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prro.2015.10.011","article-title":"Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000514914","article-title":"Stereotactic ablative radiotherapy for the management of liver metastases from neuroendocrine neoplasms: a preliminary study","volume":"112","author":"Hudson","year":"2022","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.prro.2024.09.011_bib0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2017.07.030","article-title":"Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer","volume":"99","author":"Joo","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0026","first-page":"45","article-title":"High versus low dose stereotactic body radiation therapy for hepatic metastases","volume":"20","author":"Kok","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fonc.2012.00008","article-title":"Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes","volume":"2","author":"Kress","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0028","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13014-018-0969-2","article-title":"Stereotactic body radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch Patient Registry","volume":"13","author":"Mahadevan","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0029","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijrobp.2017.04.010","article-title":"Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases","volume":"99","author":"McPartlin","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0030","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ijrobp.2020.11.045","article-title":"The Dutch-Belgian registry of stereotactic body radiation therapy for liver metastases: clinical outcomes of 515 patients and 668 metastases","volume":"109","author":"M\u00e9ndez Romero","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.rpor.2016.10.003","article-title":"Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy","volume":"22","author":"M\u00e9ndez Romero","year":"2017","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.prro.2024.09.011_bib0032","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1245\/s10434-015-4579-z","article-title":"A phase I dose-escalation trial of single-fraction stereotactic radiation therapy for liver metastases","volume":"23","author":"Meyer","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0033","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00432-020-03223-9","article-title":"Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases","volume":"146","author":"Nicosia","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.breast.2018.09.006","article-title":"Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy","volume":"42","author":"Onal","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.prro.2024.09.011_bib0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rpor.2016.07.006","article-title":"Image guided SBRT for multiple liver metastases with ExacTrac Adaptive Gating","volume":"22","author":"Rubio","year":"2017","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.prro.2024.09.011_bib0036","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1245\/s10434-010-1405-5","article-title":"Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases","volume":"18","author":"Rule","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0037","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0038","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13014-018-1185-9","article-title":"Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5\u2009years of follow-up","volume":"13","author":"Scorsetti","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0039","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4143\/crt.2017.594","article-title":"Long-term survival in patients treated with a robotic radiosurgical device for liver metastases","volume":"51","author":"Stintzing","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.prro.2024.09.011_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3857\/roj.2020.00976","article-title":"Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience","volume":"39","author":"Ugurluer","year":"2021","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2024.09.011_bib0041","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/bjs.6895","article-title":"Stereotactic body radiation therapy for colorectal liver metastases","volume":"97","author":"van der Pool","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.prro.2024.09.011_bib0042","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ijrobp.2010.12.047","article-title":"Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?","volume":"81","author":"Vautravers-Dewas","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0043","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1186\/s12885-021-08488-y","article-title":"Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival","volume":"21","author":"Voglhuber","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2024.09.011_bib0044","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/OTT.S58409","article-title":"Stereotactic body radiation therapy using the CyberKnife system for patients with liver metastases","volume":"7","author":"Yuan","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.prro.2024.09.011_bib0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.surg.2013.03.009","article-title":"Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis","volume":"154","author":"Aliyev","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.prro.2024.09.011_bib0046","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1148\/radiol.2015142489","article-title":"Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes\u2013a 10-year experience at a single center","volume":"278","author":"Shady","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2024.09.011_bib0047","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21037\/hbsn.2019.06.08","article-title":"Role of thermal ablation in the management of colorectal liver metastasis","volume":"9","author":"Takahashi","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.prro.2024.09.011_bib0048","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/bjs.9649","article-title":"Long-term outcomes following microwave ablation for liver malignancies","volume":"102","author":"Leung","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.prro.2024.09.011_bib0049","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/SLA.0000000000000234","article-title":"Microwave ablation for hepatic malignancies: a multiinstitutional analysis","volume":"259","author":"Groeschl","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2024.09.011_bib0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2023.03.064","article-title":"Transarterial chemoembolization with drug-eluting beads versus stereotactic body radiation therapy for hepatocellular carcinoma: outcomes from a multicenter, randomized, phase 2 trial (the TRENDY trial)","volume":"117","author":"M\u00e9ndez Romero","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0051","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2019.12.004","article-title":"Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review","volume":"145","author":"Lee","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0052","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00432-018-2692-7","article-title":"Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation","volume":"144","author":"Franzese","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.prro.2024.09.011_bib0053","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijrobp.2017.12.014","article-title":"Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases","volume":"100","author":"Jackson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0054","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2016.03.050","article-title":"Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy","volume":"95","author":"Ahmed","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.09.011_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107284","article-title":"Stereotactic body radiotherapy for lung oligo-metastases: systematic review and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Mayinger","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2024.09.011_bib0056","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.3390\/cancers13174303","article-title":"Thermal ablation versus stereotactic ablative body radiotherapy to treat unresectable colorectal liver metastases: a comparative analysis from the prospective Amsterdam CORE registry","volume":"13","author":"Nieuwenhuizen","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024002728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024002728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T07:14:12Z","timestamp":1754723652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024002728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1879850024002728"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.09.011","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation therapy for Liver Metastases: Systematic Review and Meta-Analysis With International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}